Target intelligence / Profile preview

Poliovirus Type 3 Capsid Protein (Saukett Strain) (PV3 Capsid (Saukett))

Target
PV3 Capsid (Saukett)
Molecular classification
Viral Structural Protein, Capsid Protein
01

Overview

The poliovirus type 3 capsid protein antigen (Saukett strain) is a structural protein complex derived from the Saukett strain of poliovirus serotype 3. This antigen, composed of VP1, VP2, VP3, and VP4, is a key component in the formulation of inactivated polio vaccines, where it serves as the immunogenic target to elicit protective antibody responses against poliovirus type 3. Recombinant forms are also used for research.

Other names
Poliovirus 3 CapsidPV3 Capsid ProteinSaukett Strain CapsidVP1, VP2, VP3, VP4 (Poliovirus 3 Saukett)Poliovirus Type 3 Saukett strain capsid protein antigen
02

Mechanism of action

Target of neutralizing antibodies; antigen used to elicit immune responses in vaccines.

03

Biological functions

Viral assemblyHost cell entryAntigen presentationInduction of immune response
04

Disease associations

PoliomyelitisViral infection
05

Safety considerations

Potential for incomplete inactivation in vaccine productionRisk of reversion to virulence (in oral polio vaccine)Allergic reactions to vaccine components
06

Interacting drugs

Formalin (inactivated vaccines)

1 more in the full profile.

07

Biomarkers

Antibody titers against PV3 capsidNeutralization assaysT cell responses to capsid proteins

Beyond the preview

Go deeper on Poliovirus Type 3 Capsid Protein (Saukett Strain) (PV3 Capsid (Saukett)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliovirus Type 3 Capsid Protein (Saukett Strain) (PV3 Capsid (Saukett)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call